SCHEMBL24363697

SCHEMBL24363697

CCC(C)c1cc(C(=O)N2CCOCC2)c2ncn(CC)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 3/20 0.47
▸ TAF1 P21675 3/20 0.47
▸ CECR2 Q9BXF3 3/20 0.47
▸ BRD9 Q9H8M2 3/20 0.47
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ USP2 O75604 1/20 0.38
▸ HTT P42858 2/20 0.38
▸ GAA P10253 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ GLA P06280 1/20 0.36
▸ RORC P51449 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19651852 0.91 BRD4 (0.48) BRD4TAF1CECR2BRD9KMT2A
SCHEMBL19657115 0.83 BRD4 (0.50) BRD4TAF1CECR2BRD9KMT2A
SCHEMBL19651854 0.77 HSP90AA1 (0.46) BRD4TAF1CECR2BRD9KMT2A
SCHEMBL19657105 0.68 CECR2 (0.47) BRD4TAF1CECR2BRD9NPC1
SCHEMBL14094387 0.68 KMT2A (0.65) KMT2AMEN1NPC1RAB9AHSP90AA1
SCHEMBL19651856 0.68 HSP90AB1 (0.46) BRD4TAF1CECR2BRD9KMT2A
SCHEMBL29482218 0.67 RORC (0.40) BRD4TAF1CECR2BRD9KMT2A
SCHEMBL17758611 0.67 RORC (0.40) BRD4TAF1CECR2BRD9KMT2A
SCHEMBL12569940 0.66 L3MBTL1 (0.56) KMT2AMEN1NPC1RAB9AHSP90AA1
SCHEMBL7361803 0.65 HDAC1 (0.46) BRD9KMT2AMEN1NPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3218375-B1 SUBSTITUTED PYRROLOPYRDINES AS INHIBITORS OF BROMODOMAIN GENENTECH INC (US) 2022-04-27 — — EP disclosed
Send feedback